Tiziana Life Sciences Ltd (TLSA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.46
• Market Cap: $178.15M
• EPS: $-0.12
• 52-Week High: $2.60
• 52-Week Low: $0.73

Market Sentiment

Tiziana Life Sciences Ltd currently has a Bullish sentiment score of 0.58.

About Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the discovery and development of innovative therapeutic molecules and diagnostics aimed at addressing unmet medical needs in oncology and immunology. Headquartered in the UK, the company is leveraging its proprietary technologies to advance a pipeline of novel therapeutics, including treatment candidates for various cancers and autoimmune diseases. With a strong focus on science and patient outcomes, Tizia...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tiziana Life Sciences Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TLSA pay dividends?

Tiziana Life Sciences Ltd (TLSA) does not currently pay a regular dividend.

What is TLSA's market cap?

Tiziana Life Sciences Ltd (TLSA) has a market capitalization of $178.15M with a current stock price of $1.46.